Le Lézard
Classified in: Health, Business
Subjects: CXP, FVT

IVX Health Announces North Carolina Expansion with Two New Infusion Centers in Piedmont Triad


GREENSBORO, N.C., Oct. 19, 2023 /PRNewswire/ -- IVX Health, a national provider of outpatient infusion and injection centers, today announced its continued expansion in North Carolina with two new infusion centers opening in Greensboro and Winston-Salem. The addition of the Piedmont Triad market brings IVX Health's existing North Carolina footprint to eight centers across three markets ? and growing.   

IVX's infusion centers in Piedmont Triad will be conveniently located in Greensboro and Winston-Salem. The Greensboro location is currently open and accepting new patients, with the Winston-Salem center slated to open in November 2023.

IVX Health's unique care model is intentionally designed to provide a world-class experience in a welcoming, safe, and private environment. All centers have an expertly trained team of nurse practitioners and registered nurses that are overseen by a local medical director ? with a nurse-to-patient staffing ratio that never exceeds 1:3. IVX Health's safety standards and protocols are similar to those found in a hospital-based setting.

"We are thrilled to continue expanding our footprint in North Carolina with the opening of the Piedmont Triad market," said Jennifer LaMar, regional operations director with IVX Health. "Our commitment to clinical excellence is why referring specialists such as gastroenterologists, rheumatologists, neurologists, and others in North Carolina choose IVX Health for their biologic infusion and injection patients. We truly believe there is no better place to receive ongoing biologic therapy than IVX."

All IVX Health centers include guaranteed private suites and flexible scheduling ? with appointments available after work and school as well as on Saturdays. Centers also feature amenities such as TVs with streaming options, comfortable recliners, and complimentary snacks.

"I have been receiving infusions at IVX Health for the past three years," said Cam Wiggins, current biologic patient at IVX Health. "The team truly cares about me and my health. Their relationships and constant support have ensured I never felt alone during my diagnosis ? and for that ? I couldn't be more grateful."

Learn more about Cam's story here.

This year has been one of sustained growth for IVX Health. The company has launched markets in multiple new states and expanded locations in current territories. Members of its executive team were recognized for their leadership efforts and IVX was named one of the Best Places to Work in Healthcare by Modern Healthcare for the fifth consecutive year. By the end of 2023, IVX Health will operate over 85 centers across the United States.

For more information on IVX Health and its services, visit www.ivxhealth.com.

IVX Health Piedmont Triad

IVX Health Greensboro
4205 W Wendover Ave, Suite D
Greensboro, NC 27407
Phone: (336) 510-2625
Fax: (336) 790-2200

IVX Health Winston-Salem
205 S Stratford Rd, Suite N-A
Winston-Salem, NC 27103
Phone: (336) 510-2991
Fax: (336) 790-2200

About IVX Health

IVX Health is a national provider of infusion and injection therapy for those with complex chronic conditions such as rheumatoid arthritis, Crohn's disease, multiple sclerosis, and other conditions.

IVX Health's national footprint of outpatient infusion centers are conveniently located in the communities where patients live and work. IVX Health's experience-first model includes amenities such as flexible appointment scheduling with evening and weekend availability, guaranteed private suites, high-speed Wi-Fi, flat screen TVs with streaming TV and movies, and comfortable recliners with room for guests. For more information on IVX Health and its existing locations, visit www.ivxhealth.com.

SOURCE IVX Health


These press releases may also interest you

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...



News published on and distributed by: